7/104 sources · 2 publishersUpdated Oct 8, 21:45 UTC
Aurora advises shareholders to take no action as Curaleaf’s revised $5 per share hostile bid remains under review
Aurora Cannabis told its shareholders to wait on Curaleaf Holdings' revised hostile takeover offer, which proposes US$5.00 per Aurora share in cash and stock. The company's special committee of independent directors will evaluate the proposal before issuing a formal recommendation. Shareholders have until at least 11:59 pm Mountain Time on December 4, 2026, to consider the bid.
Why it matters
Investors must hold off on any transaction until Aurora’s board releases its recommendation, meaning no immediate change to ownership or price is expected. The deadline extends the review period, giving shareholders more time to assess the offer.
Key facts
- 1Curaleaf’s revised implied consideration is US$5.00 per Aurora share, consisting of 0.4013 Curaleaf shares plus US$1.00 cash. prnewswire.com
- 2Aurora’s special committee of independent directors will review the revised bid before making a recommendation. prnewswire.com
- 3Shareholders may consider the offer until at least 11:59 pm Mountain Time on December 4, 2026. prnewswire.com
- 4Aurora previously recommended shareholders take no action on September 2, 2026. prnewswire.com
- 5Analysts rate Aurora (ACB) as Hold with a C$7.00 price target. tipranks.com
Summary written by AlphAI from 4 of 4 sources. Not investment advice. Figures are as stated by the linked sources.